Delivery Order SPE2DB22D9239-SPE2DB25FDL44
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,661.78 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a task order issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is scheduled for completion by August 13, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.999 billion through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,965.88 by the Defense Logistics Agency's Medical Supply Chain division on August 5, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $12,508.77 by the Defense Logistics Agency's Medical Supply Chain division. This delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a task order under the company's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The award carries no...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $54,863.74 by the Defense Logistics Agency's Medical Supply Chain division. This delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a task order against DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $242,935.80 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain division. This delivery order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a continuation of the company's role as a critical supplier within the federal pharmaceutical supply chain. The award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $54,863.74 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This delivery order, issued under the larger SPE2DB Indefinite Delivery Contract (valued at $499,999,999 and valid through November 2026), requires performance at the company's Park Ridge facility with an ultimate completion date...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,262.44 by the Defense Logistics Agency's Medical Supply Chain division on August 15, 2025. The delivery order, with an ultimate completion date of August 18, 2025, represents one of numerous purchase orders issued under DMS Pharmaceutical Group's larger $500 million indefinite delivery contract with the Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $37,693.80 by the Defense Logistics Agency's Medical Supply Chain division on August 13, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, carries no set-aside designation and represents performance at the contractor's Park Ridge location. The award leverages DMS Pharmaceutical Group's position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,762.20 by the Defense Logistics Agency's Medical Supply Chain division on August 21, 2025. This delivery order represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, a single-award vehicle valued at $499,999,999 and effective through November 2026. The contract...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL44Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, valued at $87,418.08, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. The contract carries no set-aside designation and is scheduled for completion by September 22, 2025, with performance occurring at the contractor's facility in Park Ridge, Illinois. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group maintains a robust portfolio of federal contract awards encompassing diverse medical products ranging from specialty medications to oncology treatments and biologics. This delivery order represents one of numerous firm fixed-price pharmaceutical procurements issued to the contractor, demonstrating its established capability to deliver specialized pharmaceutical items directly to Department of Defense healthcare sites. The accelerated completion timeline reflects the time-sensitive nature of pharmaceutical supply requirements within the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $87.4k | 8/29/25 |